Integral Derivatives’s Humana HUM Stock Holding History

Integral Derivatives’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,638	Closed	-$714K	–	817
2017 Q4	$654K	Buy	2,638 +137	+5%	+$33.8K	0.01%	632
2017 Q3	$609K	Sell	2,501 -5,080	-67%	-$1.24M	0.01%	660
2017 Q2	$1.82M	Buy	7,581 +4,830	+176%	+$1.09M	0.04%	323
2017 Q1	$567K	Buy	+2,751	New	+$569K	0.01%	705
2016 Q4	–	Sell	-2,691	Closed	-$513K	–	1195
2016 Q3	$476K	Buy	+2,691	New	+$467K	0.01%	645
2016 Q1	–	Sell	-4,686	Closed	-$836K	–	972
2015 Q4	$836K	Buy	4,686 +2,500	+114%	+$439K	0.02%	522
2015 Q3	$391K	Buy	+2,186	New	+$404K	0.01%	781
2014 Q2	–	Sell	-3,618	Closed	-$428K	–	1412
2014 Q1	$408K	Buy	+3,618	New	+$377K	0.01%	950

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Integral Derivatives's HUM Position: Q1 2018 in Review

Integral Derivatives sold out of Humana (HUM) in Q1 2018, closing a stake of 2,638 shares — an estimated $714K sold.

Integral Derivatives first reported a position in HUM in Q1 2014 and held it in 8 quarters. The position peaked at $1.82M in Q2 2017. 683 funds tracked by Wall St. Rank hold HUM as of Q1 2018.

Integral Derivatives reported no remaining Humana position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 2,638 Humana shares in Q1 2018, an estimated $714K.
Integral Derivatives first reported a position in Humana in Q1 2014 and held it in 8 quarters.
Integral Derivatives's Humana position peaked at $1.82M in Q2 2017.
683 funds tracked by Wall St. Rank held Humana as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.